Cargando…

Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease

BACKGROUND: Several markers have been identified to increase the risk for acute exacerbation of interstitial lung disease (AE-ILD) or mortality related to AE-ILD. However, less is known about the risk predictors of ILD patients who have survived AE. The aim of the study was to characterise AE-ILD su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salonen, Johanna, Jansa, Sanna, Vähänikkilä, Hannu, Kaarteenaho, Riitta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315035/ https://www.ncbi.nlm.nih.gov/pubmed/37393286 http://dx.doi.org/10.1186/s12890-023-02534-0

Ejemplares similares

Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Decline in Mast Cell Density During Diffuse Alveolar Damage in Idiopathic Pulmonary Fibrosis
por: Salonen, Johanna, et al.
Publicado: (2021)

Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetings
por: Salonen, Johanna, et al.
Publicado: (2023)

The challenges in classifying rheumatoid arthritis-associated interstitial lung disease
por: Nurmi, Hanna, et al.
Publicado: (2020)

Diffuse Alveolar Damage: A Common Phenomenon in Progressive Interstitial Lung Disorders
por: Kaarteenaho, Riitta, et al.
Publicado: (2011)

Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis
por: Wu, Tingting, et al.
Publicado: (2022)

Bronchoalveolar-Lavage-Derived Fibroblast Cell Lines Provide Tools for Investigating Various Interstitial Lung Diseases
por: Lehtonen, Siri, et al.
Publicado: (2022)

Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?
por: Nurmi, Hanna M., et al.
Publicado: (2017)

National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care
por: Salonen, Johanna, et al.
Publicado: (2022)

Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017)

Acute exacerbation in interstitial lung disease
por: Alhamad, Esam H., et al.
Publicado: (2021)

Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases
por: Mononen, Minna, et al.
Publicado: (2022)

Inflammatory myositis-associated interstitial lung disease can be distinguished from that associated with other connective tissue diseases
por: Nurmi, Hanna M., et al.
Publicado: (2023)

Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
por: Wang, Ye, et al.
Publicado: (2023)

Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes
por: Nurmi, Hanna M., et al.
Publicado: (2016)

NHLRC2 expression is increased in idiopathic pulmonary fibrosis
por: Kreus, Mervi, et al.
Publicado: (2022)

COVID-19 and acute exacerbation of interstitial lung disease
por: Kondoh, Yasuhiro, et al.
Publicado: (2021)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2023)

The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta
Publicado: (2013)

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
por: Kobayashi, Haruki, et al.
Publicado: (2018)

Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases
por: Ito, Yoko, et al.
Publicado: (2019)

Acute exacerbations of interstitial lung disease: what is the best treatment?
por: Meyer, Keith C.
Publicado: (2021)

Acute exacerbation of interstitial lung disease in the intensive care unit
por: Charokopos, Antonios, et al.
Publicado: (2022)

Prevalence of viral infection in acute exacerbation of interstitial lung diseases in Japan
por: On, Rintaro, et al.
Publicado: (2020)

Baseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumonia
por: Sato, Yuki, et al.
Publicado: (2017)

Periodontal disease exacerbates hospitalisation
por: Wadia, Reena
Publicado: (2021)

KL-6 as an Immunological Biomarker Predicts the Severity, Progression, Acute Exacerbation, and Poor Outcomes of Interstitial Lung Disease: A Systematic Review and Meta-Analysis
por: Zhang, Tao, et al.
Publicado: (2021)

A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease
por: Kamiya, Hiroyuki, et al.
Publicado: (2021)

Acute Exacerbation of Interstitial Lung Disease as a Sequela of COVID-19 Pneumonia
por: Fonseca, Mario, et al.
Publicado: (2021)

Combined ultrasound–CT approach to monitor acute exacerbation of interstitial lung disease
por: Mongodi, Silvia, et al.
Publicado: (2020)

Cyclophosphamide for the treatment of Acute Exacerbation of Interstitial Lung Disease: A Review of the Literature
por: Innabi, Ayoub, et al.
Publicado: (2021)

Secondary analysis of preoperative predictors for acute postoperative exacerbation in interstitial lung disease
por: Seto, Fumiko, et al.
Publicado: (2023)

The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases
por: Lee, Jae Ha, et al.
Publicado: (2021)

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
por: Hozumi, Hironao, et al.
Publicado: (2022)

A predictive model for acute exacerbation of idiopathic interstitial pneumonias
por: Karayama, Masato, et al.
Publicado: (2023)

Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2021)

Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis
por: Yang, Ji Ae, et al.
Publicado: (2019)

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients
por: Ye, Lifang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uhcqts4355h6abt5hgqo4ta6dc